RNAC Operating Cash Flow Growth
Cartesian Therapeutics Inc · Operating Cash Flow Growth
RNAC Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-17.72%period ending
RNAC Quarterly Cash from Operations YoY % (-107.55% → -17.72%)
Year-over-year change
High-resolution chart · PNG
RNAC operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -17.7216% | |
| 4.2107% | |
| -152.9563% | |
| -213.9435% | |
| -21.2862% | |
| -45.1781% | |
| 69.9304% | |
| 248.573% | |
| -45.9929% | |
| -81.5973% | |
| -96.5229% | |
| -311.6931% | |
| 19.3627% | |
| 26.121% | |
| 62.3363% | |
| 140.5081% | |
| -103.0614% | |
| 2.2171% | |
| -333.931% | |
| -116.3719% | |
| 48.8228% | |
| -3.7186% | |
| 43.6937% | |
| 690.1546% | |
| -64.0684% | |
| 42.2036% | |
| -1.0041% | |
| 30.6219% | |
| 57.5974% | |
| -50.9434% | |
| -0.5997% | |
| -3.8614% | |
| -97.0397% | |
| 12.451% | |
| -914.3959% | |
| -182.382% | |
| -53.6294% | |
| -50.6591% | |
| 120.3665% | |
| 2.6016% | |
| -30.0023% | |
| -107.5541% |